Nicholas M. Barnes
Birmingham Research Park
Birmingham, ENG, United Kingdom
Birmingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.
Journal: British journal of pharmacology
Published: December 29, 2025
Multivariate Brain-Blood Signatures in Early-Stage Depression and Psychosis.
Journal: JAMA psychiatry
Published: December 17, 2025
Reshaping the progranulin/sortilin interaction for targeted degradation of extracellular proteins.
Journal: Cell chemical biology
Published: October 08, 2025
A Structure-Activity Relationship Study of Novel Positive Allosteric Modulators for the δ-Opioid Receptor.
Journal: ACS chemical neuroscience
Published: July 18, 2025
Current Position and Future Direction of Inflammation in Neuropsychiatric Disorders: A Review.
Journal: JAMA psychiatry
Published: July 09, 2025
P2X7R-mediated IL-1β release by human brain tissue: the impact of CNS-penetrant potential therapeutics.
Journal: Brain : a journal of neurology
Published: April 22, 2025
A systematic literature review and meta-analysis of virtual reality nature effects on higher education students' mental health and wellbeing.
Journal: Applied psychology. Health and well-being
Published: February 07, 2025
Structuring of gellan hydrogel enables the production of inherently antifibrotic, lubricating eye drops.
Journal: Acta biomaterialia
Published: January 17, 2025
Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?
Journal: British journal of pharmacology
Published: December 02, 2024
Depressive and Negative Symptoms in the Early and Established Stages of Schizophrenia: Integrating Structural Brain Alterations, Cognitive Performance, and Plasma Interleukin 6 Levels.
Journal: Biological psychiatry global open science
Published: August 19, 2024
Discovery of 2-Methyl-5-(1H-pyrazol-4-yl)pyridines and Related Heterocycles as Promising M4 mAChR Positive Allosteric Modulators for the Treatment of Neurocognitive Disorders.
Journal: Journal of medicinal chemistry
Published: July 18, 2024
Last Updated: 09/26/2026